Author

Megan H. Donahue

Observed names: Donahue, Megan, Megan Donahue

Institution: Mayo Clinic in Florida

Observed institutions: Mayo Clinic, Mayo Clinic in Florida, University of Missouri

ORCID: 0000-0002-3505-4338

Observed ORCID: 0000-0002-3505-4338

OpenAlex ID: A5105832115

TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia

2024 · Jordan D. Marks, Virginia Estades Ayuso, et al. · Science Translational Medicine · 42

Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United States

2024 · Erica Engelberg-Cook, Jaimin S. Shah, et al. · Mayo Clinic Proceedings Innovations Quality & Outcomes · 14

N-of-1 investigational study of a novel antisense oligonucleotide drug in CHCHD10-related ALS shows early signs of efficacy

2026 · Margot A. Cousin, Aditi I. Dagli, et al. · Med · 1

N-of-1 CHCHD10 ALS Antisense Oligonucleotide Trial Shows Early Signs of Efficacy

2025 · Margot A. Cousin, Aditi I. Dagli, et al. · SSRN Electronic Journal

Promoting Diversity and Inclusion in Astronomy Graduate Education

2019 · Alexander Rudolph, Gibor Basri, et al.

Astro2020: Promoting Diversity and Inclusion in Astronomy Graduate Education: an Astro2020 APC White Paper by the AAS Taskforce on Diversity and Inclusion in Astronomy Graduate Education

2019 · Rudolph, Alexander, Basri, Gibor, et al. · arXiv (Cornell University)

Assessing Student Status and Progress in Science Reasoning and Quantitative Literacy at a Very Large Undergraduate Institution

2009 · Megan Donahue, Jonathan Kaplan, et al. · AAS

Works count: 7

Citation count: 56

H-index: 2

I10-index: 2